fda compounding semaglutide enforcement news november 2025 Have patients been harmed by unsafe drug compounding? – Partnership for Safe Medicines FDA Moves to Permanently Close

What You Can Expect At GHCS, every weight management journey is personalized

Peptides (2018) 99:99107

Stick to regular resistance training and aerobic activity to preserve muscle mass and keep your metabolism steady

Tirzepatide: The Dual Agonist Tirzepatide is often referred to as the next generation GLP-1 because it targets two hormones : This dual mechanism seems to amplify its effects

GIP and GLP1 reduce appetite by signalling through their receptors that are expressed in multiple regions of the central nervous system

It works by targeting the brains hypothalamus, altering hunger signals and enhancing feelings of fullness, which supports healthier eating habits and reduces overall calorie intake